What drugs target PD-1 and TIM-3?

3+ drugs target PD-1 and TIM-3, including .

What drug classes act on PD-1 and TIM-3?

Drug classes acting on PD-1 and TIM-3 include Bispecific checkpoint inhibitor.

3 drugs 3 in Phase 3

All drugs that target PD-1 and TIM-3 — marketed and clinical-stage. Includes 1 drug classes acting on this target.

IBI363 · Innovent Biologics (Suzhou) Co. Ltd. · Bispecific checkpoint inhibitor · Oncology
IBI363 is a bispecific antibody that simultaneously engages PD-1 on immune cells and TIM-3 on T cells to enhance anti-tumor immune responses.
IBI310 · Innovent Biologics (Suzhou) Co. Ltd. · Bispecific checkpoint inhibitor · Oncology
IBI310 is a bispecific antibody that simultaneously engages PD-1 on T cells and TIM-3 on tumor-infiltrating lymphocytes to enhance anti-tumor immune responses.
AK104(IV) · Akeso · Bispecific checkpoint inhibitor · Oncology
AK104 is a bispecific antibody that simultaneously engages PD-1 on immune cells and TIM-3 on T cells to enhance anti-tumor immune responses.